Invesco Ltd. Teva Pharmaceutical Industries LTD Transaction History

Invesco Ltd.

$460 Billion
Q2 2024

A detailed history of Invesco Ltd. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Invesco Ltd. holds 4,749,590 shares of TEVA stock, worth $83.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,749,590

Previous 209,419 2167.98%

Holding current value

$83.1 Million

Previous $2.95 Million 2512.73%

% of portfolio

0.02%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$12.78 - $17.4 $58 Million - $79 Million	4,540,171 Added 2167.98%	4,749,590 $77.2 Million
Q1 2024 May 14, 2024	SELL	$10.67 - $14.43 $7,522 - $10,173	-705 Reduced 0.34%	209,419 $2.95 Million
Q4 2023 Feb 12, 2024	SELL	$8.12 - $10.63 $71,253 - $93,278	-8,775 Reduced 4.01%	210,124 $2.19 Million
Q3 2023 Nov 13, 2023	BUY	$7.48 - $10.7 $19,126 - $27,359	2,557 Added 1.18%	218,899 $2.23 Million
Q2 2023 Aug 11, 2023	SELL	$7.2 - $9.47 $362,520 - $476,814	-50,350 Reduced 18.88%	216,342 $1.63 Million
Q1 2023 May 12, 2023	SELL	$8.36 - $11.37 $953,817 - $1.3 Million	-114,093 Reduced 29.96%	266,692 $2.36 Million
Q4 2022 Feb 13, 2023	BUY	$7.95 - $9.48 $21,011 - $25,055	2,643 Added 0.7%	380,785 $3.47 Million
Q3 2022 Nov 14, 2022	BUY	$6.86 - $11.95 $97,624 - $170,060	14,231 Added 3.91%	378,142 $3.05 Million
Q2 2022 Aug 15, 2022	BUY	$7.38 - $10.4 $111,556 - $157,206	15,116 Added 4.33%	363,911 $2.74 Million
Q1 2022 May 16, 2022	BUY	$7.33 - $9.39 $30,031 - $38,470	4,097 Added 1.19%	348,795 $3.27 Million
Q4 2021 Feb 14, 2022	SELL	$7.9 - $10.19 $3.05 Million - $3.93 Million	-385,785 Reduced 52.81%	344,698 $2.76 Million
Q3 2021 Nov 15, 2021	SELL	$8.38 - $10.18 $1.98 Million - $2.4 Million	-235,841 Reduced 24.41%	730,483 $7.12 Million
Q2 2021 Aug 17, 2021	BUY	$9.9 - $11.56 $978,426 - $1.14 Million	98,831 Added 11.39%	966,324 $9.57 Million
Q1 2021 May 17, 2021	SELL	$10.34 - $12.81 $7 Million - $8.67 Million	-676,632 Reduced 43.82%	867,493 $10 Million
Q4 2020 Feb 16, 2021	BUY	$8.61 - $11.04 $1.74 Million - $2.23 Million	202,388 Added 15.08%	1,544,125 $14.9 Million
Q3 2020 Nov 16, 2020	SELL	$8.57 - $12.69 $4.14 Million - $6.13 Million	-482,973 Reduced 26.47%	1,341,737 $12.1 Million
Q2 2020 Aug 14, 2020	SELL	$8.12 - $13.12 $1.71 Million - $2.76 Million	-210,206 Reduced 10.33%	1,824,710 $22.5 Million
Q1 2020 May 15, 2020	BUY	$6.69 - $13.45 $10.7 Million - $21.4 Million	1,594,441 Added 361.98%	2,034,916 $18.3 Million
Q4 2019 Feb 14, 2020	BUY	$6.53 - $10.72 $1.78 Million - $2.92 Million	271,981 Added 161.42%	440,475 $4.32 Million
Q3 2019 Nov 14, 2019	BUY	$6.16 - $9.6 $307,494 - $479,212	49,918 Added 42.1%	168,494 $1.16 Million
Q2 2019 Aug 14, 2019	BUY	$8.12 - $15.72 $516,310 - $999,556	63,585 Added 115.63%	118,576 $1.09 Million
Q1 2019 May 15, 2019	BUY	$15.58 - $20.01 $229,493 - $294,747	14,730 Added 36.59%	54,991 $862,000
Q4 2018 Feb 14, 2019	BUY	$14.59 - $23.84 $587,407 - $959,822	40,261 New	40,261 $621,000

Others Institutions Holding TEVA

# of Institutions

617

Shares Held

563M

Call Options Held

25.2M

Put Options Held

5.08M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account